Literature DB >> 26970136

Cancer prevention in HIV-infected populations.

Priscila H Goncalves1, Jairo M Montezuma-Rusca2, Robert Yarchoan1, Thomas S Uldrick3.   

Abstract

People living with human immunodeficiency virus (HIV) are living longer since the advent of effective combined antiretroviral therapy (cART). While cART substantially decreases the risk of developing some cancers, HIV-infected individuals remain at high risk for Kaposi sarcoma, lymphoma, and several solid tumors. Currently HIV-infected patients represent an aging group, and malignancies have become a leading cause of morbidity and mortality. Tailored cancer-prevention strategies are needed for this population. In this review we describe the etiologic agents and pathogenesis of common malignancies in the setting of HIV, as well as current evidence for cancer prevention strategies and screening programs. Published by Elsevier Inc.

Entities:  

Keywords:  AIDS-related lymphoma; HIV; HPV vaccines; Kaposi sarcoma; Neoplasms

Mesh：

Substances：

Year:  2015        PMID： 26970136      PMCID： PMC4789150          DOI： 10.1053/j.seminoncol.2015.09.011

Source DB:  PubMed          Journal:  Semin Oncol        ISSN： 0093-7754            Impact factor:   4.929


  233 in total

1.  Safety and immunogenicity of a quadrivalent human papillomavirus (types 6, 11, 16, and 18) vaccine in HIV-infected children 7 to 12 years old.

Authors:  Myron J Levin; Anna-Barbara Moscicki; Lin-Ye Song; Terrence Fenton; William A Meyer; Jennifer S Read; Edward L Handelsman; Barbara Nowak; Carlos A Sattler; Alfred Saah; David R Radley; Mark T Esser; Adriana Weinberg
Journal:  J Acquir Immune Defic Syndr       Date:  2010-10       Impact factor: 3.731

2.  Loss of EBNA1-specific memory CD4+ and CD8+ T cells in HIV-infected patients progressing to AIDS-related non-Hodgkin lymphoma.

Authors:  Erwan Piriou; Karel van Dort; Nening M Nanlohy; Marinus H J van Oers; Frank Miedema; Debbie van Baarle
Journal:  Blood       Date:  2005-07-12       Impact factor: 22.113

3.  Balance of apoptotic and anti-apoptotic marker and perforin granule release in squamous intraepithelial lesions. HIV infection leads to a decrease in perforin degranulation.

Authors:  Ana Teresa G Fernandes; Natalia Pereira da Rocha; Elyzabeth Avvad; Beatriz J Grinsztejn; Fabio Russomano; Aparecida Tristão; Marcel de Souza Borges Quintana; Mauricio A Perez; Fátima Conceição-Silva; Maria da Gloria Bonecini-Almeida
Journal:  Exp Mol Pathol       Date:  2013-06-17       Impact factor: 3.362

4.  Trends in cancer risk among people with AIDS in the United States 1980-2002.

Authors:  Eric A Engels; Ruth M Pfeiffer; James J Goedert; Phillip Virgo; Timothy S McNeel; Steven M Scoppa; Robert J Biggar
Journal:  AIDS       Date:  2006-08-01       Impact factor: 4.177

5.  Sofosbuvir and ribavirin for hepatitis C in patients with HIV coinfection.

Authors:  Mark S Sulkowski; Susanna Naggie; Jacob Lalezari; Walford Jeffrey Fessel; Karam Mounzer; Margaret Shuhart; Anne F Luetkemeyer; David Asmuth; Anuj Gaggar; Liyun Ni; Evguenia Svarovskaia; Diana M Brainard; William T Symonds; G Mani Subramanian; John G McHutchison; Maribel Rodriguez-Torres; Douglas Dieterich
Journal:  JAMA       Date:  2014 Jul 23-30       Impact factor: 56.272

6.  Aspirin attenuates platelet activation and immune activation in HIV-1-infected subjects on antiretroviral therapy: a pilot study.

Authors:  Meagan O'Brien; Emilie Montenont; Liang Hu; Michael A Nardi; Vanessa Valdes; Michael Merolla; Gabrielle Gettenberg; Karen Cavanagh; Judith A Aberg; Nina Bhardwaj; Jeffrey S Berger
Journal:  J Acquir Immune Defic Syndr       Date:  2013-07-01       Impact factor: 3.731

7.  Longer duration of combination antiretroviral therapy reduces the risk of Hodgkin lymphoma: A cohort study of HIV-infected male veterans.

Authors:  M A Kowalkowski; M A Mims; R S Day; X L Du; W Chan; E Y Chiao
Journal:  Cancer Epidemiol       Date:  2014-06-16       Impact factor: 2.984

8.  Cutaneous malignancies among HIV-infected persons.

Authors:  Nancy Crum-Cianflone; Katherine Huppler Hullsiek; Elizabeth Satter; Vincent Marconi; Amy Weintrob; Anuradha Ganesan; R Vincent Barthel; Susan Fraser; Brian K Agan
Journal:  Arch Intern Med       Date:  2009-06-22

9.  Expression and Function of the Chemokine, CXCL13, and Its Receptor, CXCR5, in Aids-Associated Non-Hodgkin's Lymphoma.

Authors:  Daniel P Widney; Dorina Gui; Laura M Popoviciu; Jonathan W Said; Elizabeth C Breen; Xin Huang; Christina M R Kitchen; Juan M Alcantar; Jeffrey B Smith; Roger Detels; Otoniel Martínez-Maza
Journal:  AIDS Res Treat       Date:  2010-08-25

10.  Management of hepatocellular carcinoma: an update.

Authors:  Jordi Bruix; Morris Sherman
Journal:  Hepatology       Date:  2011-03       Impact factor: 17.425
View more
  17 in total

1.  Human herpesvirus-encoded kinase induces B cell lymphomas in vivo.

Authors:  Penny M Anders; Nathan D Montgomery; Stephanie A Montgomery; Aadra P Bhatt; Dirk P Dittmer; Blossom Damania
Journal:  J Clin Invest       Date:  2018-05-07       Impact factor: 14.808

2.  Reply to El-Mallawany et al.

Authors:  Julia Bohlius; Eliane Rohner; Matthias Egger
Journal:  Clin Infect Dis       Date:  2017-03-15       Impact factor: 9.079

Review 3.  Cancer immunotherapy in patients with preexisting autoimmune disorders.

Authors:  Marco Donia; Magnus Pedersen; Inge Marie Svane
Journal:  Semin Immunopathol       Date:  2016-10-11       Impact factor: 9.623

Review 4.  HIV-Associated Cancers and Related Diseases.

Authors:  Robert Yarchoan; Thomas S Uldrick
Journal:  N Engl J Med       Date:  2018-03-15       Impact factor: 91.245

Review 5.  Cancer in Transgender People: Evidence and Methodological Considerations.

Authors:  Hayley Braun; Rebecca Nash; Vin Tangpricha; Janice Brockman; Kevin Ward; Michael Goodman
Journal:  Epidemiol Rev       Date:  2017-01-01       Impact factor: 6.222

6.  Association of Immunosuppression and Human Immunodeficiency Virus (HIV) Viremia With Anal Cancer Risk in Persons Living With HIV in the United States and Canada.

Authors:  Raúl U Hernández-Ramírez; Li Qin; Haiqun Lin; Wendy Leyden; Romain S Neugebauer; Keri N Althoff; Nancy A Hessol; Chad J Achenbach; John T Brooks; M John Gill; Surbhi Grover; Michael A Horberg; Jun Li; W Christopher Mathews; Angel M Mayor; Pragna Patel; Charles S Rabkin; Anita Rachlis; Amy C Justice; Richard D Moore; Eric A Engels; Michael J Silverberg; Robert Dubrow
Journal:  Clin Infect Dis       Date:  2020-03-03       Impact factor: 9.079

7.  Cancer Risk in Older Persons Living With Human Immunodeficiency Virus Infection in the United States.

Authors:  Parag Mahale; Eric A Engels; Anna E Coghill; Amy R Kahn; Meredith S Shiels
Journal:  Clin Infect Dis       Date:  2018-06-18       Impact factor: 9.079

8.  Quitline Treatment Enrollment and Cessation Outcomes Among Smokers Linked With Treatment via Ask-Advise-Connect: Comparisons Among Smokers With and Without HIV.

Authors:  Thanh C Bui; Bárbara Piñeiro; Damon J Vidrine; David W Wetter; Summer G Frank-Pearce; Jennifer I Vidrine
Journal:  Nicotine Tob Res       Date:  2020-08-24       Impact factor: 4.244

Review 9.  HIV-associated malignancies in children.

Authors:  Elvira Singh; Gita Naidu; Mary-Ann Davies; Julia Bohlius
Journal:  Curr Opin HIV AIDS       Date:  2017-01       Impact factor: 4.283

10.  Cancer risk in HIV-infected people in the USA from 1996 to 2012: a population-based, registry-linkage study.

Authors:  Raúl U Hernández-Ramírez; Meredith S Shiels; Robert Dubrow; Eric A Engels
Journal:  Lancet HIV       Date:  2017-08-10       Impact factor: 12.767
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.